Scrip
Clinica
Scrip Regulatory Affairs
Scrip Clinical Research
AnimalPharm
Email ID
Password
Forgotten your password?
Sign me in automatically next time
Advanced Search
Home
Therapy Sector
Generics
Business
Policy & Regulation
Research & Development
International
Pricing & Reimbursement
|
Regulation
|
Healthcare Policy
|
Pharmacovigilance
|
Intellectual Property
|
Policy & Regulation Staging - Intellectual Property
About Us
Getting Started
Subscribe
Free Trial
Advertise
Awards
White Papers
Executive Briefing
Classifieds
Recruitment
JOB OF THE WEEK
Promote your vacancy here
SCRIP's ONLINE DIRECTORY
Classified ads
LATEST NEWS
MSF claims GSK's intervention reveals ACTA as a front to push for stronger IP rights
31 January 2011
New Thai govt outlines policies generally positive for indus...
AMAG, Allos to merge – but will it really bring sales synerg...
India veering towards TRIPS-plus provisions in EU trade talks?
07 January 2011
India says current IPR norms sufficient to 'checkmate' evergreening
12 October 2010
EU/India drug seizure row appears settled, but Indian firms wary of ACTA
08 October 2010
EU/South Korea trade deal includes pharma data protection and patent extensions
20 October 2009
>> More News...
LATEST ANALYSIS
Market Insight - Originator/generic competition: who's the 'bad guy'?
29 January 2010
Market Insight - Clarity needed over ASEAN regulators' position on IP
05 August 2009
Market Insight - After the dawn raids
19 August 2008
>> More Analysis...
LATEST FEATURES
Face-to-face: EU defends the need for anti-counterfeiting treaty
01 July 2009
>> More Features...
LATEST COMMENT
Commentary - EC final report: bark worse than bite?
23 July 2009
Patent attack - The interim findings of the European Commission's pharmaceutical sector inquiry
15 December 2008
>> More Comment...
REFINE BY
COMPANY/ORGANISATION
NOVARTIS
PFIZER
GLAXOSMITHKLINE
SANOFI-AVENTIS
CONDITION
CANCER
DIABETES
HIV
PAIN
GEOGRAPHY
INDIA
CHINA
JAPAN
BRAZIL
DRUG
RITONAVIR
EFAVIRENZ
IPAB
AMLODIPINE
